Higher Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis: A Comparison with a Control Group of Noninflammatory Rheumatologic Conditions-Reference-Cited by-同舟云学术

Higher Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis: A Comparison with a Control Group of Noninflammatory Rheumatologic Conditions

Published:2016-02 Issue:2 Volume:43 Page:463-464
ISSN:0315-162X
Container-title:The Journal of Rheumatology
language:en
Short-container-title:J Rheumatol

Author:

HAROON MUHAMMAD,RAFIQ CHAUDHRY ADNAN BIN,FITZGERALD OLIVER

Publisher

The Journal of Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. High Prevalence of Metabolic Syndrome and of Insulin Resistance in Psoriatic Arthritis is Associated with the Severity of Underlying Disease

2. Diagnosis and Management of the Metabolic Syndrome

3. Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis

4. Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study

5. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HEPATOSTEATOZ DEĞERLENDİRMEDE ETKİN BİR ÖLÇEĞİN PSÖRİATİK ARTRİTLİ HASTALARDA KULLANIMI: DOKU ATENUASYON GÖRÜNTÜLEME;Kırıkkale Üniversitesi Tıp Fakültesi Dergisi;2024-08-20

2. Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-08

3. Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis;Therapeutic Advances in Musculoskeletal Disease;2023-01

4. Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study;Frontiers in Medicine;2022-05-19

5. Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use;Canadian Liver Journal;2021-11-01